Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients

Laryngoscope

Volumn 108, Issue 10, 1998, Pages 1435-1441

  Blitzer, Andrew ^a,b,e   Brin, Mitchell F ^a,c   Stewart, Celia F ^a,b,d  

^a New York Center for Voice and Swallowing Disorders   (United States)

^b Head and Neck Surgical Group   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ARTICLE; DISEASE COURSE; DYSPHONIA; DYSTONIA; ELECTROMYOGRAPHY; HUMAN; INJECTION; MUSCLE WEAKNESS; PRIORITY JOURNAL; SPEECH; TREATMENT OUTCOME; VOCAL CORD PARALYSIS;

ADULT; BOTULINUM TOXIN TYPE A; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VOICE DISORDERS;

EID: 0031717677     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199810000-00003     Document Type: Article

References (36)

1. Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical and laboratory characteristics of laryngeal dystonia: a study of 110 cases. Laryngoscope 1988;98:636-40.
2. Brin MF, Fahn S, Blitzer A, Ramig LO, Stewart C. Movement disorders of the larynx. In: Blitzer A, Brin MF, Sasaki CT, Fahn S, Harris K, eds. Neurological Disorders of the Larynx. New York: Thieme; 1992: 240-8.
3. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100:85-90.
4. Cannito MP, Johnson P. Spastic dysphonia: a continuum disorder. J Commun Disord 1981;14:215-23.
5. Grillone G, Blitzer A, Brin MF. Treatment of adductor breathing dystonia with botulinum toxin. Laryngoscope 1994; 104:30-3.
6. Braun N, Abd A, Baer J, Blitzer A, Stewart C, Brin MF. Dyspnea in dystonia. Chest 1995;107:1309-16.
7. Aronson AE, Brown JR, Litin EM, Pearson JS. Spastic dysphonia, II. Comparison with essential (voice) tremor and other neurologic dysphonias. J Speech Hearing Disord 1968;33:219-31.
8. Ludlow CL, Naunton RF, Bassich CJ. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section. Otolaryngol Head Neck Surg 1984;92:24-31.
9. Blitzer A, Lovelace RE, Brin MF, Fahn S. Electromyographic findings in focal laryngeal dystonia (dysphonia). Ann Otol Rhinol Laryngol 1985;94:591-4.
10. Marsden CD, Sheehy MP. Spastic dysphonia, Meige disease and torsion dystonia. Neurology 1982;32:1202-3.
11. Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985;108:463-83.
12. Zweig RM, Hedreen JC, Jankel WR, Casanova MF, Whitehouse PJ. Pathology in brainstem regions of individuals with primary dystonia. Neurology 1988;38:702-6.
13. Ozelius L, Kramer PL, Moskowitz CB, et al. Human gene for torsion dystonia located on chromosome 9q32-34. Ann Neurol 1990;27:114-20.
14. Wilhelmsen KC, Weeks DE, Nygaard TG, et al. Genetic mapping of the 'Lubag' (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol 1991;29:124-31.
15. Fahn S, Moskowitz C. X-linked recessive dystonia and parkinsonism in Filipino males [abstract]. Ann Neurol 1988;24:179.
16. Kupke KG, Lee LV, Muller U. Assignment of the X-linked tortion dystonia gene to Xq21 by linkage analysis. Neurology 1990;40:1438-42.
17. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41:174-81.
18. Ozelius LJ, Kramer PL, deLeon D, et al. Strong allelic association between the tortion dystonia gene (DTY1) and loci on chromosome 9q34 in Ashkenazi Jews. Am J Human Genet 1992;50:619-28.
19. Bressman SB, de Leon D, Kramer PL, et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol 1994;36:771-7.
20. Bressman SB, Heiman GA, Nygaard TG, et al. A study of idiopathic tortion dystonia in a non-Jewish family: evidence for genetic heterogeneity. Neurology 1994;44:283-87.
21. Kramer PL, de Leon D, Ozelius L, et al. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol 1990;27:114-20.
22. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet 1994;8:236-42.
23. Scott AB. Clostridial toxins as therapeutic agents. In: Simpson LL, ed. Botulinum Neurotoxin and Tetanus Toxin. New York: Academic Press; 1989:399-412.
24. Binz T, Blasi J, Yamasaki S, Baumeister A, Link E, Sudhop TC, Jahn R, Nieman H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 1994; 269: 1617-20.
25. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal folds for spasmodic dysphonia. Arch Otol Head Neck Surg 1987;113:603-5.
26. Ludlow CL, Naunton RF, Sedory SE, Schultz SE, Schultz GN, Hallett M. Effects of botulinum toxin injection on speech in adductor spasmodic dysphonia. Neurology 1988; 38:1220-5.
27. Ford CN, Bless DM, Lowery JD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otol Head Neck Surg 1990;103:752-8.
28. Rhew K, Fiedler DA, Ludlow CL. Technique for injection of botulinum toxin through a flexible nasolaryngoscope. Otolaryngol- Head Neck Surg 1994;111:787-94.
29. Koufman JA. New classification of laryngeal dystonias. The Visible Voice 1992;1:1-5.
30. Morrison M, Rammage L. Musculoskeletal approach to the classification of dysphonias. In: The Management of Voice Disorders. San Diego: Singular Publishing Group; 1994: 53-63.
31. Schaefer SD. Neuropathology of spasmodic dysphonia. Laryngoscope 1983;93:1183-204.
32. Darley FL, Aronson AE, Brown JR. Motor Speech Disorders. Philadelphia: WB Saunders; 1975:25.
33. Bassich CJ, Ludlow CL. The use of perceptual methods by new clinicians for assessing voice quality. J Speech Hear Dis 1986;51:125-33.
34. Aronson AE. Clinical Voice Disorders New York: Thieme; 1985:5.
35. Blitzer A, Brin MF, Stewart C, Fahn S. Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope 1992;102:163-7.
36. Ludlow CF, Naunton RF, Terada S. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injections. Otolaryngol Head Neck Surg 1991;104:849.